MENLO PARK, Calif.,
Jan. 27, 2016 /PRNewswire/
-- BioPharmX Corporation (NYSE MKT: BPMX), a specialty
pharmaceutical company focusing on dermatology and women's health,
today announced that Craig A.
Barbarosh has joined the company's board of directors. He
will serve as an independent board member on the audit and
compensation committees and will chair the nominating and corporate
governance committee.
![BioPharmX (BPMX) BioPharmX (BPMX)](http://photos.prnewswire.com/prnvar/20150711/235327LOGO)
Barbarosh is a member of the board of directors of Sabra Health
Care REIT, Inc., which operates 170 healthcare facilities across
the United States and Canada, where he serves as chairman of the
audit committee and is a member of its compensation committee.
Barbarosh is also an independent director and vice chairman of the
board at Quality Systems, Inc., a leading healthcare information
technology company, where he serves as the chairman of the
nominating and governance committee and a member of the
compensation and transaction committees of the board, as well as a
director of the company's wholly-owned India subsidiary.
Barbarosh is also a partner at a major international law firm,
and is a recognized expert in corporate governance and
organization. Barbarosh has participated in more than 150
financial and operational restructurings throughout the United States and has counseled clients on
varied complex business transactions.
Chambers USA, which has been
ranking the best lawyers since 1990, called Barbarosh an
"incredibly measured and practical negotiator" who has an
"impressive ability to manage large, complex matters."
"Craig's deep experience in matters of corporate governance and
organization will serve BioPharmX well as we continue to grow our
pipeline and expand our organization," said Jim Pekarsky, chief executive officer and
co-founder of BioPharmX Corporation. "His legal insight will be
particularly useful when we begin to actively pursue licensing
opportunities as the products in our pipeline pass regulatory
milestones."
"I am particularly excited to join the board of BioPharmX
because it is on the cutting-edge of developing groundbreaking
products to address unmet medical needs in dermatology and women's
health," Barbarosh said. "I am very impressed with the company's
product pipeline and management team and I am looking forward to
helping BioPharmX advance its strategic growth and expand its
business."
Barbarosh received his law degree from University of the Pacific McGeorge School of Law,
where he graduated with honors, and a bachelor's degree in Business
Economics from University of California, Santa
Barbara.
About BioPharmX® Corporation
BioPharmX Corporation (NYSE MKT: BPMX) is a Silicon Valley-based
specialty pharmaceutical company, which seeks to provide products
through proprietary platform technologies for prescription,
over-the-counter (OTC), and supplement applications in the health
and wellness markets, including dermatology and women's health. To
learn more about BioPharmX, visit www.BioPharmX.com.
Forward-Looking Statements
Statements in this news release relating to the business of
BioPharmX, which are not historical facts, are "forward-looking
statements." These forward-looking statements may be
identified by words such as "expect," "anticipate," "believe," or
similar expressions that are intended to identify such
forward-looking statements. All forward-looking statements
are expressly qualified in their entirety by this cautionary
statement and the risks and other factors detailed in the company's
filings with the Securities and Exchange Commission (SEC). These
statements are based upon the current expectations and beliefs of
management and are subject to certain risks and uncertainties that
could cause actual results to differ materially from those
described in the forward-looking statements, including the risk
that the company's efforts to grow its pipeline, develop its
products and expand its business are unsuccessful. Given these
risks and uncertainties, you are cautioned not to place undue
reliance on such forward-looking statements. The
forward-looking statements included in this news release are made
only as of the date hereof and the company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as may be required under applicable securities law.
BioPharmX and Violet are registered trademarks of BioPharmX,
Inc. All other brand and product names are trademarks or registered
trademarks of their respective holders.
Logo - http://photos.prnewswire.com/prnh/20150711/235327LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biopharmx-corporation-appoints-craig-a-barbarosh-to-its-board-of-directors-300210196.html
SOURCE BioPharmX Corporation